Aim: Older patients with chronic kidney disease (CKD) are more likely to be excluded from clinical trials. This exclusion affects the quality of cardiovascular disease (CVD) prevention in this population.
Methods: Baseline data from the Fukuoka Kidney Disease Registry (FKR) cohort, which included 4476 adult patients with CKD stages G1–G5, were cross-sectionally analyzed to compare the use of recommended drugs for preventing CVD in each age group.
Results: Different prescribing patterns were observed according to age for the cardiovascular drug classes. Older patients with CKD were less likely to receive renin–angiotensin system (RAS) inhibitors and were more likely to receive calcium channel blockers. The proportion of anticoagulation prescriptions for patients with CKD and atrial fibrillation decreased in the older age group (≥ 75 years). However, the proportion of antiplatelet therapy in patients with ischemic CVD increased linearly with age, even in the very old group aged ≥ 85 years. These findings suggest a severe cardiovascular burden in patients with CKD. Notably, RAS inhibitor use was avoided in the older group despite a severe cardiovascular burden, such as a high prevalence of CVD history and massive albuminuria ＞300 mg/g creatinine. This finding indicates that an older age independently contributed to the non-use of RAS inhibitors, even after adjusting for other covariates.
Conclusions: This study suggests that age is a potential barrier to the treatment of patients with CKD and highlights the need to establish individualized treatment strategies for cardiovascular protection in this population.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410020209538083840","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Tanaka Shigeru"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410020209538083844","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kitamura Hiromasa"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410020209538083842","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Tsuruya Kazuhiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Nephrology, Nara Medical University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410020209538083843","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kitazono Takanari"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}]},{"@id":"https://cir.nii.ac.jp/crid/1410020209538083841","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Nakano Toshiaki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"13403478"},{"@type":"EISSN","@value":"18803873"}],"prism:publicationName":[{"@language":"en","@value":"Journal of Atherosclerosis and Thrombosis"},{"@language":"ja","@value":"Ｊｏｕｒｎａｌ ｏｆ Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ ａｎｄ Ｔｈｒｏｍｂｏｓｉｓ"},{"@language":"en","@value":"JAT"},{"@language":"en","@value":"J Atheroscler Thromb"},{"@language":"ja","@value":"Ｊ Ａｔｈｅｒｏｓｃｌｅｒ Ｔｈｒｏｍｂ"}],"dc:publisher":[{"@language":"en","@value":"Japan Atherosclerosis Society"},{"@language":"ja","@value":"一般社団法人 日本動脈硬化学会"}],"prism:publicationDate":"2024-10-01","prism:volume":"31","prism:number":"10","prism:startingPage":"1427","prism:endingPage":"1442"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://www.jstage.jst.go.jp/article/jat/31/10/31_64798/_pdf"},{"@id":"https://search.jamas.or.jp/link/ui/2025276959"}],"availableAt":"2024-10-01","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Cardiovascular%20disease","dc:title":"Cardiovascular disease"},{"@id":"https://cir.nii.ac.jp/all?q=Older%20people","dc:title":"Older people"},{"@id":"https://cir.nii.ac.jp/all?q=Drug","dc:title":"Drug"},{"@id":"https://cir.nii.ac.jp/all?q=Renin%E2%80%93angiotensin%20system%20inhibitor","dc:title":"Renin–angiotensin system inhibitor"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040578979262794624","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23K19818"},{"@type":"JGN","@value":"JP23K19818"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23K19818/"}],"notation":[{"@language":"ja","@value":"血液透析患者のサルコペニア進展が認知機能に及ぼす影響の検討：コホート研究"},{"@language":"en","@value":"Emerging Link between Sarcopenia Progression and Cognitive Impairment in Patients Undergoing Hemodialysis: A Prospective Cohort Study"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004231988145408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients ≥80 years of age: Observations from the CREDO-Kyoto Registry Cohort-2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360018681964298368","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Real‐World Clinical Characteristics and Treatment Patterns of Individuals Aged 80 and Older with Nonvalvular Atrial Fibrillation: Results from the ReAl‐life Multicenter Survey Evaluating Stroke Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360018683086344576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Use of cardiovascular medications in the elderly"}]},{"@id":"https://cir.nii.ac.jp/crid/1360300155950375424","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ischemic Stroke and Secondary Prevention in Clinical Practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360300157284687360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impact of age on cardiovascular drug use in patients with chronic kidney disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360300159402998144","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Angiotensin-converting enzyme inhibitors in heart failure: Physicians' prescribing behavior"}]},{"@id":"https://cir.nii.ac.jp/crid/1360581633534315136","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Cost-Effectiveness of Preference-Based Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846640278539904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570915493376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The Fukuoka Kidney disease Registry (FKR) Study: design and methods"}]},{"@id":"https://cir.nii.ac.jp/crid/1360863105853596032","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impact of comorbidity on medication use in elderly patients with cardiovascular diseases: the OCTOCARDIO study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360863105922127744","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Age and Persistent Use of Cardiovascular Medication After Acute Coronary Syndrome: Results from Medication Applied and Sustained Over Time"}]},{"@id":"https://cir.nii.ac.jp/crid/1360863106478826752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"The role of comprehensive geriatric assessment and functional status in evaluating the patterns of antithrombotic use among older people with atrial fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045848935808","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Persistent Use of Secondary Preventive Drugs Declines Rapidly During the First 2 Years After Stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699995981138432","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981468540408832","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"A Randomized Trial of Intensive versus Standard Blood-Pressure Control"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471260981376","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction"}]},{"@id":"https://cir.nii.ac.jp/crid/1362544420175966848","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Effects of Intensive BP Control in CKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895359767296","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388845814054016","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670319578106752","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320610658944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269199759360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1390015830352303104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiovascular Risk Factor Burden and Treatment Control in Patients with Chronic Kidney Disease: A Cross-Sectional Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390294276475486336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Association of Kidney Function with Serum Levels of Cholesterol Absorption and Synthesis Markers: The CACHE Study CKD Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390297305329028352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Hyperhomocysteinemia Increases Vascular Risk in Stroke Patients with Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390855886882242816","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390858608252797696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Association of Controlling Nutritional Status Score and Prognostic Nutritional Index with Cardiovascular Diseases: the Fukuoka Kidney Disease Registry Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390860929791507328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2013383904"},{"@type":"CROSSREF","@value":"10.5551/jat.64798"},{"@type":"PUBMED","@value":"38631869"},{"@type":"KAKEN","@value":"PRODUCT-25829130"},{"@type":"OPENAIRE","@value":"doi_dedup___::b652a730b67e30b1a2188916d7a7defe"}]}